首页> 外文期刊>Antiviral Research >Expression, purification and immunogenic characterization of hepatitis C virus recombinant E1E2 protein expressed by Pichia pastoris yeast.
【24h】

Expression, purification and immunogenic characterization of hepatitis C virus recombinant E1E2 protein expressed by Pichia pastoris yeast.

机译:巴斯德毕赤酵母表达的丙型肝炎病毒重组E1E2蛋白的表达,纯化和免疫原性表征。

获取原文
获取原文并翻译 | 示例
       

摘要

Development of an effective vaccine may be the key in the control of hepatitis C virus (HCV) infection. Recent studies have shown that HCV envelope proteins can induce broadly neutralizing antibodies against conserved domain for HCV binding to the cellular receptors. So HCV envelope proteins are considered as the major HCV vaccine candidate. In this study, we used Pichia pastoris yeast to express truncated HCV E1E2 protein, which consists of E1 residues 187-346 and E2 residues 381-699. The yeast can produce high level of recombinant HCV E1E2 protein. The protein has complex glycosylation and can bind to CD81, the putative HCV receptor. Moreover, the purified protein can efficiently induce anti-E1E2 antibodies in rabbits, which are able to neutralize two kinds of HCV pseudotype particles derived from HCV genotype 1a and 1b, as well as HCV virions derived from HCV genotype 2a. These findings indicate that the recombinant E1E2 glycoprotein is effective in inducing broadly neutralizing antibodies, and is a potent HCV vaccine candidate.
机译:开发有效的疫苗可能是控制丙型肝炎病毒(HCV)感染的关键。最近的研究表明,HCV包膜蛋白可以诱导针对HCV与细胞受体结合的保守域的广泛中和抗体。因此,HCV包膜蛋白被认为是主要的HCV疫苗候选者。在这项研究中,我们使用巴斯德毕赤酵母表达截短的HCV E1E2蛋白,该蛋白由E1残基187-346和E2残基381-699组成。该酵母可产生高水平的重组HCV E1E2蛋白。该蛋白具有复杂的糖基化作用,可以与假定的HCV受体CD81结合。此外,纯化的蛋白可以在兔中有效诱导抗E1E2抗体,该抗体能够中和源自HCV基因型1a和1b的两种HCV假型颗粒以及源自HCV基因型2a的HCV病毒体。这些发现表明,重组E1E2糖蛋白可有效诱导广泛中和的抗体,并且是有效的HCV疫苗候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号